Edwards Lifesciences Posts Higher 1Q Profit, Sales
By Kimberly Chin
Edwards Lifesciences Corp. posted higher earnings in the first
quarter, driven by an increase in sales as the company saw a rise
in structural heart procedures during the period.
The medical device company reported earnings of $338.2 million,
up from $310.6 million in the comparable period a year earlier.
Per-share earnings were 54 cents, up from 49 cents a year ago.
Adjusted earnings were 54 cents a share. Analysts were expecting
reported earnings of 46 cents a share and adjusted earnings of 47
cents a share, according to a FactSet poll.
Net sales rose to $1.22 billion from $1.13 billion a year
earlier. Analysts were looking for $1.16 billion.
"Structural heart procedures increased as we progressed through
the winter months, and our sales growth this quarter was better
than expected," Chief Executive Michael Mussallem said in prepared
Write to Kimberly Chin at email@example.com
(END) Dow Jones Newswires
April 20, 2021 16:43 ET (20:43 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.